Nomura Holdings, Inc. (NMR) Stock Competitors & Peer Comparison
See (NMR) competitors and their performances in Stock Market.
Peer Comparison Table: Financial - Capital Markets Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NMR | $8.73 | +1.69% | 25.5B | 11.77 | $0.74 | +4.83% |
| MS-PQ | $25.45 | +0.24% | 334.2B | N/A | N/A | +1.94% |
| MS | $215.18 | +1.39% | 331.6B | 19.04 | $11.04 | +1.94% |
| GS | $1,067.89 | +2.19% | 304.5B | 18.83 | $54.80 | +1.70% |
| GS-PD | $19.09 | -0.39% | 203.8B | 0.37 | $51.53 | +1.70% |
| GS-PA | $19.40 | -0.03% | 200.3B | 0.38 | $51.53 | +1.70% |
| SCHW | $91.51 | +3.89% | 154.4B | 17.65 | $5.03 | +1.32% |
| SCHW-PJ | $17.44 | +0.52% | 153.3B | 6.27 | $2.77 | +1.32% |
| SCHW-PD | $24.30 | +0.19% | 152.8B | 8.74 | $2.77 | +1.32% |
| HOOD | $93.45 | +9.89% | 75.4B | 40.67 | $2.06 | N/A |
Stock Comparison
NMR vs MS-PQ Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS-PQ has a market cap of 334.2B. Regarding current trading prices, NMR is priced at $8.73, while MS-PQ trades at $25.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS-PQ's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PQ's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to MS-PQ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PQ's competition here
NMR vs MS Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS has a market cap of 331.6B. Regarding current trading prices, NMR is priced at $8.73, while MS trades at $215.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS's P/E ratio is 19.04. In terms of profitability, NMR's ROE is +0.10%, compared to MS's ROE of +0.16%. Regarding short-term risk, NMR is less volatile compared to MS. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MS's competition here
NMR vs GS Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GS has a market cap of 304.5B. Regarding current trading prices, NMR is priced at $8.73, while GS trades at $1,067.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GS's P/E ratio is 18.83. In terms of profitability, NMR's ROE is +0.10%, compared to GS's ROE of +0.15%. Regarding short-term risk, NMR is less volatile compared to GS. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GS's competition here
NMR vs GS-PD Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GS-PD has a market cap of 203.8B. Regarding current trading prices, NMR is priced at $8.73, while GS-PD trades at $19.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GS-PD's P/E ratio is 0.37. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PD's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PD's competition here
NMR vs GS-PA Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GS-PA has a market cap of 200.3B. Regarding current trading prices, NMR is priced at $8.73, while GS-PA trades at $19.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GS-PA's P/E ratio is 0.38. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PA's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PA. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PA's competition here
NMR vs SCHW Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SCHW has a market cap of 154.4B. Regarding current trading prices, NMR is priced at $8.73, while SCHW trades at $91.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SCHW's P/E ratio is 17.65. In terms of profitability, NMR's ROE is +0.10%, compared to SCHW's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to SCHW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SCHW's competition here
NMR vs SCHW-PJ Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SCHW-PJ has a market cap of 153.3B. Regarding current trading prices, NMR is priced at $8.73, while SCHW-PJ trades at $17.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SCHW-PJ's P/E ratio is 6.27. In terms of profitability, NMR's ROE is +0.10%, compared to SCHW-PJ's ROE of +0.19%. Regarding short-term risk, NMR is more volatile compared to SCHW-PJ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SCHW-PJ's competition here
NMR vs SCHW-PD Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SCHW-PD has a market cap of 152.8B. Regarding current trading prices, NMR is priced at $8.73, while SCHW-PD trades at $24.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SCHW-PD's P/E ratio is 8.74. In terms of profitability, NMR's ROE is +0.10%, compared to SCHW-PD's ROE of +0.19%. Regarding short-term risk, NMR is more volatile compared to SCHW-PD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SCHW-PD's competition here
NMR vs HOOD Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, HOOD has a market cap of 75.4B. Regarding current trading prices, NMR is priced at $8.73, while HOOD trades at $93.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas HOOD's P/E ratio is 40.67. In terms of profitability, NMR's ROE is +0.10%, compared to HOOD's ROE of +0.22%. Regarding short-term risk, NMR is less volatile compared to HOOD. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HOOD's competition here
NMR vs GS-PJ Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GS-PJ has a market cap of 68.9B. Regarding current trading prices, NMR is priced at $8.73, while GS-PJ trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GS-PJ's P/E ratio is 0.49. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PJ's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PJ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PJ's competition here
NMR vs MS-PA Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS-PA has a market cap of 68.5B. Regarding current trading prices, NMR is priced at $8.73, while MS-PA trades at $19.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS-PA's P/E ratio is 2.47. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PA's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to MS-PA. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PA's competition here
NMR vs MS-PI Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS-PI has a market cap of 66.7B. Regarding current trading prices, NMR is priced at $8.73, while MS-PI trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS-PI's P/E ratio is 3.18. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PI's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to MS-PI. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PI's competition here
NMR vs MS-PF Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS-PF has a market cap of 65.6B. Regarding current trading prices, NMR is priced at $8.73, while MS-PF trades at $25.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS-PF's P/E ratio is 3.23. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PF's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to MS-PF. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PF's competition here
NMR vs MS-PE Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS-PE has a market cap of 64.9B. Regarding current trading prices, NMR is priced at $8.73, while MS-PE trades at $25.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS-PE's P/E ratio is 3.25. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PE's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to MS-PE. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PE's competition here
NMR vs GS-PK Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GS-PK has a market cap of 64.7B. Regarding current trading prices, NMR is priced at $8.73, while GS-PK trades at $25.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GS-PK's P/E ratio is 0.49. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PK's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PK. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PK's competition here
NMR vs MS-PK Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS-PK has a market cap of 63.9B. Regarding current trading prices, NMR is priced at $8.73, while MS-PK trades at $23.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS-PK's P/E ratio is 2.99. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PK's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to MS-PK. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PK's competition here
NMR vs MS-PP Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS-PP has a market cap of 39.9B. Regarding current trading prices, NMR is priced at $8.73, while MS-PP trades at $25.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS-PP's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PP's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to MS-PP. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PP's competition here
NMR vs MS-PL Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS-PL has a market cap of 30.9B. Regarding current trading prices, NMR is priced at $8.73, while MS-PL trades at $19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS-PL's P/E ratio is 2.49. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PL's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to MS-PL. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PL's competition here
NMR vs RJF Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, RJF has a market cap of 29.5B. Regarding current trading prices, NMR is priced at $8.73, while RJF trades at $154.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas RJF's P/E ratio is 14.19. In terms of profitability, NMR's ROE is +0.10%, compared to RJF's ROE of +0.17%. Regarding short-term risk, NMR is less volatile compared to RJF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check RJF's competition here
NMR vs MS-PO Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MS-PO has a market cap of 26.5B. Regarding current trading prices, NMR is priced at $8.73, while MS-PO trades at $16.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MS-PO's P/E ratio is 2.14. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PO's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to MS-PO. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PO's competition here
NMR vs LPLA Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, LPLA has a market cap of 23.1B. Regarding current trading prices, NMR is priced at $8.73, while LPLA trades at $293.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas LPLA's P/E ratio is 25.92. In terms of profitability, NMR's ROE is +0.10%, compared to LPLA's ROE of +0.17%. Regarding short-term risk, NMR is less volatile compared to LPLA. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LPLA's competition here
NMR vs CRCL Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, CRCL has a market cap of 21.7B. Regarding current trading prices, NMR is priced at $8.73, while CRCL trades at $78.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas CRCL's P/E ratio is -352.61. In terms of profitability, NMR's ROE is +0.10%, compared to CRCL's ROE of -0.03%. Regarding short-term risk, NMR is less volatile compared to CRCL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CRCL's competition here
NMR vs TW Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, TW has a market cap of 21.2B. Regarding current trading prices, NMR is priced at $8.73, while TW trades at $100.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas TW's P/E ratio is 24.61. In terms of profitability, NMR's ROE is +0.10%, compared to TW's ROE of +0.14%. Regarding short-term risk, NMR is less volatile compared to TW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TW's competition here
NMR vs STRD Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, STRD has a market cap of 20.3B. Regarding current trading prices, NMR is priced at $8.73, while STRD trades at $70.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas STRD's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to STRD's ROE of -0.24%. Regarding short-term risk, NMR is more volatile compared to STRD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check STRD's competition here
NMR vs IREN Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, IREN has a market cap of 19.3B. Regarding current trading prices, NMR is priced at $8.73, while IREN trades at $60.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas IREN's P/E ratio is 70.16. In terms of profitability, NMR's ROE is +0.10%, compared to IREN's ROE of +0.03%. Regarding short-term risk, NMR is less volatile compared to IREN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check IREN's competition here
NMR vs EVR Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, EVR has a market cap of 13.8B. Regarding current trading prices, NMR is priced at $8.73, while EVR trades at $360.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas EVR's P/E ratio is 20.11. In terms of profitability, NMR's ROE is +0.10%, compared to EVR's ROE of +0.41%. Regarding short-term risk, NMR is less volatile compared to EVR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check EVR's competition here
NMR vs FUTU Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, FUTU has a market cap of 12.7B. Regarding current trading prices, NMR is priced at $8.73, while FUTU trades at $97.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas FUTU's P/E ratio is 10.08. In terms of profitability, NMR's ROE is +0.10%, compared to FUTU's ROE of +0.27%. Regarding short-term risk, NMR is less volatile compared to FUTU. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FUTU's competition here
NMR vs HUT Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, HUT has a market cap of 12.7B. Regarding current trading prices, NMR is priced at $8.73, while HUT trades at $119.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas HUT's P/E ratio is -39.95. In terms of profitability, NMR's ROE is +0.10%, compared to HUT's ROE of -0.21%. Regarding short-term risk, NMR is less volatile compared to HUT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HUT's competition here
NMR vs WULF Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, WULF has a market cap of 12.5B. Regarding current trading prices, NMR is priced at $8.73, while WULF trades at $26.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas WULF's P/E ratio is -10.08. In terms of profitability, NMR's ROE is +0.10%, compared to WULF's ROE of -8.50%. Regarding short-term risk, NMR is less volatile compared to WULF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check WULF's competition here
NMR vs JEF Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, JEF has a market cap of 12.1B. Regarding current trading prices, NMR is priced at $8.73, while JEF trades at $61.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas JEF's P/E ratio is 19.81. In terms of profitability, NMR's ROE is +0.10%, compared to JEF's ROE of +0.07%. Regarding short-term risk, NMR is less volatile compared to JEF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check JEF's competition here
NMR vs VIRT Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, VIRT has a market cap of 11.5B. Regarding current trading prices, NMR is priced at $8.73, while VIRT trades at $56.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas VIRT's P/E ratio is 9.03. In terms of profitability, NMR's ROE is +0.10%, compared to VIRT's ROE of +0.36%. Regarding short-term risk, NMR is less volatile compared to VIRT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check VIRT's competition here
NMR vs SF Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SF has a market cap of 11B. Regarding current trading prices, NMR is priced at $8.73, while SF trades at $72.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SF's P/E ratio is 13.92. In terms of profitability, NMR's ROE is +0.10%, compared to SF's ROE of +0.15%. Regarding short-term risk, NMR is less volatile compared to SF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SF's competition here
NMR vs GLXY Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GLXY has a market cap of 10.8B. Regarding current trading prices, NMR is priced at $8.73, while GLXY trades at $33.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GLXY's P/E ratio is -136.17. In terms of profitability, NMR's ROE is +0.10%, compared to GLXY's ROE of -0.04%. Regarding short-term risk, NMR is less volatile compared to GLXY. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GLXY's competition here
NMR vs HLI Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, HLI has a market cap of 9.7B. Regarding current trading prices, NMR is priced at $8.73, while HLI trades at $138.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas HLI's P/E ratio is 22.68. In terms of profitability, NMR's ROE is +0.10%, compared to HLI's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to HLI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HLI's competition here
NMR vs SNEX Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SNEX has a market cap of 9.7B. Regarding current trading prices, NMR is priced at $8.73, while SNEX trades at $131.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SNEX's P/E ratio is 21.80. In terms of profitability, NMR's ROE is +0.10%, compared to SNEX's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to SNEX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SNEX's competition here
NMR vs SCE-PJ Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SCE-PJ has a market cap of 9.6B. Regarding current trading prices, NMR is priced at $8.73, while SCE-PJ trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SCE-PJ's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to SCE-PJ's ROE of N/A. Regarding short-term risk, NMR is more volatile compared to SCE-PJ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SCE-PJ's competition here
NMR vs RIOT Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, RIOT has a market cap of 9.6B. Regarding current trading prices, NMR is priced at $8.73, while RIOT trades at $26.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas RIOT's P/E ratio is -10.16. In terms of profitability, NMR's ROE is +0.10%, compared to RIOT's ROE of -0.29%. Regarding short-term risk, NMR is less volatile compared to RIOT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check RIOT's competition here
NMR vs CIFR Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, CIFR has a market cap of 9.4B. Regarding current trading prices, NMR is priced at $8.73, while CIFR trades at $25.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas CIFR's P/E ratio is -9.93. In terms of profitability, NMR's ROE is +0.10%, compared to CIFR's ROE of -1.18%. Regarding short-term risk, NMR is less volatile compared to CIFR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CIFR's competition here
NMR vs BGCG Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, BGCG has a market cap of 9.4B. Regarding current trading prices, NMR is priced at $8.73, while BGCG trades at $25.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas BGCG's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to BGCG's ROE of +0.00%. Regarding short-term risk, NMR is more volatile compared to BGCG. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check BGCG's competition here
NMR vs BMNR Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, BMNR has a market cap of 8.7B. Regarding current trading prices, NMR is priced at $8.73, while BMNR trades at $16.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas BMNR's P/E ratio is -2.18. In terms of profitability, NMR's ROE is +0.10%, compared to BMNR's ROE of -1.64%. Regarding short-term risk, NMR is less volatile compared to BMNR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BMNR's competition here
NMR vs FRHC Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, FRHC has a market cap of 8.7B. Regarding current trading prices, NMR is priced at $8.73, while FRHC trades at $138.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas FRHC's P/E ratio is 56.52. In terms of profitability, NMR's ROE is +0.10%, compared to FRHC's ROE of +0.11%. Regarding short-term risk, NMR is less volatile compared to FRHC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FRHC's competition here
NMR vs XP Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, XP has a market cap of 8.2B. Regarding current trading prices, NMR is priced at $8.73, while XP trades at $16.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas XP's P/E ratio is 7.98. In terms of profitability, NMR's ROE is +0.10%, compared to XP's ROE of +0.22%. Regarding short-term risk, NMR is less volatile compared to XP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check XP's competition here
NMR vs GS-PC Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GS-PC has a market cap of 7.6B. Regarding current trading prices, NMR is priced at $8.73, while GS-PC trades at $19.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GS-PC's P/E ratio is 1.57. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PC's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PC. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PC's competition here
NMR vs GSIW Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GSIW has a market cap of 6.6B. Regarding current trading prices, NMR is priced at $8.73, while GSIW trades at $29.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GSIW's P/E ratio is -0.86. In terms of profitability, NMR's ROE is +0.10%, compared to GSIW's ROE of -0.57%. Regarding short-term risk, NMR is less volatile compared to GSIW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GSIW's competition here
NMR vs PIPR Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, PIPR has a market cap of 5.6B. Regarding current trading prices, NMR is priced at $8.73, while PIPR trades at $79.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas PIPR's P/E ratio is 19.98. In terms of profitability, NMR's ROE is +0.10%, compared to PIPR's ROE of +0.22%. Regarding short-term risk, NMR is less volatile compared to PIPR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PIPR's competition here
NMR vs RJF-PA Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, RJF-PA has a market cap of 5.4B. Regarding current trading prices, NMR is priced at $8.73, while RJF-PA trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas RJF-PA's P/E ratio is 3.54. In terms of profitability, NMR's ROE is +0.10%, compared to RJF-PA's ROE of +0.17%. Regarding short-term risk, NMR is more volatile compared to RJF-PA. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check RJF-PA's competition here
NMR vs MC Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MC has a market cap of 5.3B. Regarding current trading prices, NMR is priced at $8.73, while MC trades at $69.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MC's P/E ratio is 25.46. In terms of profitability, NMR's ROE is +0.10%, compared to MC's ROE of +0.42%. Regarding short-term risk, NMR is less volatile compared to MC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MC's competition here
NMR vs BGC Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, BGC has a market cap of 5.2B. Regarding current trading prices, NMR is priced at $8.73, while BGC trades at $11.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas BGC's P/E ratio is 29.65. In terms of profitability, NMR's ROE is +0.10%, compared to BGC's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to BGC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BGC's competition here
NMR vs FIGR Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, FIGR has a market cap of 5.2B. Regarding current trading prices, NMR is priced at $8.73, while FIGR trades at $27.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas FIGR's P/E ratio is 34.49. In terms of profitability, NMR's ROE is +0.10%, compared to FIGR's ROE of +0.18%. Regarding short-term risk, NMR is less volatile compared to FIGR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FIGR's competition here
NMR vs MARA Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MARA has a market cap of 5.1B. Regarding current trading prices, NMR is priced at $8.73, while MARA trades at $14.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MARA's P/E ratio is -2.44. In terms of profitability, NMR's ROE is +0.10%, compared to MARA's ROE of -0.52%. Regarding short-term risk, NMR is less volatile compared to MARA. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MARA's competition here
NMR vs LAZ Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, LAZ has a market cap of 4.7B. Regarding current trading prices, NMR is priced at $8.73, while LAZ trades at $43.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas LAZ's P/E ratio is 18.77. In terms of profitability, NMR's ROE is +0.10%, compared to LAZ's ROE of +0.33%. Regarding short-term risk, NMR is less volatile compared to LAZ. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LAZ's competition here
NMR vs MRX Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MRX has a market cap of 4.4B. Regarding current trading prices, NMR is priced at $8.73, while MRX trades at $62.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MRX's P/E ratio is 13.72. In terms of profitability, NMR's ROE is +0.10%, compared to MRX's ROE of +0.26%. Regarding short-term risk, NMR is less volatile compared to MRX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MRX's competition here
NMR vs PJT Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, PJT has a market cap of 4.2B. Regarding current trading prices, NMR is priced at $8.73, while PJT trades at $154.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas PJT's P/E ratio is 23.48. In terms of profitability, NMR's ROE is +0.10%, compared to PJT's ROE of +0.76%. Regarding short-term risk, NMR is less volatile compared to PJT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PJT's competition here
NMR vs MKTX Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MKTX has a market cap of 4.1B. Regarding current trading prices, NMR is priced at $8.73, while MKTX trades at $120.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MKTX's P/E ratio is 13.79. In terms of profitability, NMR's ROE is +0.10%, compared to MKTX's ROE of +0.24%. Regarding short-term risk, NMR is less volatile compared to MKTX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MKTX's competition here
NMR vs MIAX Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MIAX has a market cap of 3.8B. Regarding current trading prices, NMR is priced at $8.73, while MIAX trades at $43.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MIAX's P/E ratio is 30.85. In terms of profitability, NMR's ROE is +0.10%, compared to MIAX's ROE of +0.15%. Regarding short-term risk, NMR is less volatile compared to MIAX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MIAX's competition here
NMR vs SF-PB Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SF-PB has a market cap of 3.5B. Regarding current trading prices, NMR is priced at $8.73, while SF-PB trades at $23.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SF-PB's P/E ratio is 3.47. In terms of profitability, NMR's ROE is +0.10%, compared to SF-PB's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to SF-PB. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF-PB's competition here
NMR vs ETOR Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, ETOR has a market cap of 3.2B. Regarding current trading prices, NMR is priced at $8.73, while ETOR trades at $38.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas ETOR's P/E ratio is 16.31. In terms of profitability, NMR's ROE is +0.10%, compared to ETOR's ROE of +0.17%. Regarding short-term risk, NMR is less volatile compared to ETOR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ETOR's competition here
NMR vs SF-PC Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SF-PC has a market cap of 2.3B. Regarding current trading prices, NMR is priced at $8.73, while SF-PC trades at $22.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SF-PC's P/E ratio is 3.33. In terms of profitability, NMR's ROE is +0.10%, compared to SF-PC's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to SF-PC. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF-PC's competition here
NMR vs BGCP Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, BGCP has a market cap of 1.7B. Regarding current trading prices, NMR is priced at $8.73, while BGCP trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas BGCP's P/E ratio is 40.27. In terms of profitability, NMR's ROE is +0.10%, compared to BGCP's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to BGCP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BGCP's competition here
NMR vs SF-PD Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SF-PD has a market cap of 1.6B. Regarding current trading prices, NMR is priced at $8.73, while SF-PD trades at $16.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SF-PD's P/E ratio is 2.42. In terms of profitability, NMR's ROE is +0.10%, compared to SF-PD's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to SF-PD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF-PD's competition here
NMR vs CIFRW Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, CIFRW has a market cap of 1.6B. Regarding current trading prices, NMR is priced at $8.73, while CIFRW trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas CIFRW's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to CIFRW's ROE of -1.18%. Regarding short-term risk, NMR is less volatile compared to CIFRW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CIFRW's competition here
NMR vs HKIB Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, HKIB has a market cap of 1.5B. Regarding current trading prices, NMR is priced at $8.73, while HKIB trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas HKIB's P/E ratio is 6.68. In terms of profitability, NMR's ROE is +0.10%, compared to HKIB's ROE of +0.14%. Regarding short-term risk, NMR is less volatile compared to HKIB. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HKIB's competition here
NMR vs PWP Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, PWP has a market cap of 1.4B. Regarding current trading prices, NMR is priced at $8.73, while PWP trades at $15.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas PWP's P/E ratio is 61.24. In terms of profitability, NMR's ROE is +0.10%, compared to PWP's ROE of -0.09%. Regarding short-term risk, NMR is less volatile compared to PWP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PWP's competition here
NMR vs BITF Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, BITF has a market cap of 1.3B. Regarding current trading prices, NMR is priced at $8.73, while BITF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas BITF's P/E ratio is -5.68. In terms of profitability, NMR's ROE is +0.10%, compared to BITF's ROE of -0.70%. Regarding short-term risk, NMR is less volatile compared to BITF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BITF's competition here
NMR vs GOLD Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GOLD has a market cap of 1.2B. Regarding current trading prices, NMR is priced at $8.73, while GOLD trades at $44.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GOLD's P/E ratio is 13.64. In terms of profitability, NMR's ROE is +0.10%, compared to GOLD's ROE of +0.12%. Regarding short-term risk, NMR is less volatile compared to GOLD. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GOLD's competition here
NMR vs PURR Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, PURR has a market cap of 1.2B. Regarding current trading prices, NMR is priced at $8.73, while PURR trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas PURR's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to PURR's ROE of -0.23%. Regarding short-term risk, NMR is less volatile compared to PURR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PURR's competition here
NMR vs AMRK Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, AMRK has a market cap of 1.2B. Regarding current trading prices, NMR is priced at $8.73, while AMRK trades at $46.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas AMRK's P/E ratio is 155.73. In terms of profitability, NMR's ROE is +0.10%, compared to AMRK's ROE of +0.12%. Regarding short-term risk, NMR is less volatile compared to AMRK. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check AMRK's competition here
NMR vs COWN Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, COWN has a market cap of 1.1B. Regarding current trading prices, NMR is priced at $8.73, while COWN trades at $38.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas COWN's P/E ratio is 17.64. In terms of profitability, NMR's ROE is +0.10%, compared to COWN's ROE of +0.07%. Regarding short-term risk, NMR is more volatile compared to COWN. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check COWN's competition here
NMR vs OPY Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, OPY has a market cap of 1.1B. Regarding current trading prices, NMR is priced at $8.73, while OPY trades at $104.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas OPY's P/E ratio is 11.60. In terms of profitability, NMR's ROE is +0.10%, compared to OPY's ROE of +0.10%. Regarding short-term risk, NMR is less volatile compared to OPY. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check OPY's competition here
NMR vs SBET Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SBET has a market cap of 1B. Regarding current trading prices, NMR is priced at $8.73, while SBET trades at $5.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SBET's P/E ratio is -0.60. In terms of profitability, NMR's ROE is +0.10%, compared to SBET's ROE of -0.74%. Regarding short-term risk, NMR is less volatile compared to SBET. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SBET's competition here
NMR vs ABTC Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, ABTC has a market cap of 942.9M. Regarding current trading prices, NMR is priced at $8.73, while ABTC trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas ABTC's P/E ratio is -6.56. In terms of profitability, NMR's ROE is +0.10%, compared to ABTC's ROE of -0.30%. Regarding short-term risk, NMR is less volatile compared to ABTC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ABTC's competition here
NMR vs DFIN Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, DFIN has a market cap of 935.6M. Regarding current trading prices, NMR is priced at $8.73, while DFIN trades at $38.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas DFIN's P/E ratio is 27.34. In terms of profitability, NMR's ROE is +0.10%, compared to DFIN's ROE of +0.09%. Regarding short-term risk, NMR is less volatile compared to DFIN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check DFIN's competition here
NMR vs TIGR Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, TIGR has a market cap of 843.5M. Regarding current trading prices, NMR is priced at $8.73, while TIGR trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas TIGR's P/E ratio is 7.74. In terms of profitability, NMR's ROE is +0.10%, compared to TIGR's ROE of +0.14%. Regarding short-term risk, NMR is less volatile compared to TIGR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TIGR's competition here
NMR vs LCLN Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, LCLN has a market cap of 746.2M. Regarding current trading prices, NMR is priced at $8.73, while LCLN trades at $24.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas LCLN's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to LCLN's ROE of N/A. Regarding short-term risk, NMR is less volatile compared to LCLN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LCLN's competition here
NMR vs AC Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, AC has a market cap of 652.2M. Regarding current trading prices, NMR is priced at $8.73, while AC trades at $30.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas AC's P/E ratio is 12.17. In terms of profitability, NMR's ROE is +0.10%, compared to AC's ROE of +0.03%. Regarding short-term risk, NMR is less volatile compared to AC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check AC's competition here
NMR vs BTBT Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, BTBT has a market cap of 614.6M. Regarding current trading prices, NMR is priced at $8.73, while BTBT trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas BTBT's P/E ratio is -4.00. In terms of profitability, NMR's ROE is +0.10%, compared to BTBT's ROE of -0.00%. Regarding short-term risk, NMR is less volatile compared to BTBT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BTBT's competition here
NMR vs GEMI Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GEMI has a market cap of 544.9M. Regarding current trading prices, NMR is priced at $8.73, while GEMI trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GEMI's P/E ratio is -0.97. In terms of profitability, NMR's ROE is +0.10%, compared to GEMI's ROE of -1.97%. Regarding short-term risk, NMR is less volatile compared to GEMI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GEMI's competition here
NMR vs RJF-PB Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, RJF-PB has a market cap of 422.6M. Regarding current trading prices, NMR is priced at $8.73, while RJF-PB trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas RJF-PB's P/E ratio is 0.30. In terms of profitability, NMR's ROE is +0.10%, compared to RJF-PB's ROE of +0.17%. Regarding short-term risk, NMR is less volatile compared to RJF-PB. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check RJF-PB's competition here
NMR vs MFH Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, MFH has a market cap of 390.3M. Regarding current trading prices, NMR is priced at $8.73, while MFH trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas MFH's P/E ratio is -70.63. In terms of profitability, NMR's ROE is +0.10%, compared to MFH's ROE of -0.06%. Regarding short-term risk, NMR is less volatile compared to MFH. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MFH's competition here
NMR vs FUFUW Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, FUFUW has a market cap of 289.1M. Regarding current trading prices, NMR is priced at $8.73, while FUFUW trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas FUFUW's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to FUFUW's ROE of -0.29%. Regarding short-term risk, NMR is less volatile compared to FUFUW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FUFUW's competition here
NMR vs FUFU Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, FUFU has a market cap of 289.1M. Regarding current trading prices, NMR is priced at $8.73, while FUFU trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas FUFU's P/E ratio is -5.83. In terms of profitability, NMR's ROE is +0.10%, compared to FUFU's ROE of -0.29%. Regarding short-term risk, NMR is less volatile compared to FUFU. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FUFU's competition here
NMR vs GHL Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GHL has a market cap of 282M. Regarding current trading prices, NMR is priced at $8.73, while GHL trades at $14.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GHL's P/E ratio is -10.27. In terms of profitability, NMR's ROE is +0.10%, compared to GHL's ROE of +0.04%. Regarding short-term risk, NMR is more volatile compared to GHL. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GHL's competition here
NMR vs CSHR Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, CSHR has a market cap of 266.6M. Regarding current trading prices, NMR is priced at $8.73, while CSHR trades at $4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas CSHR's P/E ratio is 2.33. In terms of profitability, NMR's ROE is +0.10%, compared to CSHR's ROE of +0.22%. Regarding short-term risk, NMR is less volatile compared to CSHR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CSHR's competition here
NMR vs BTGO Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, BTGO has a market cap of 226.6M. Regarding current trading prices, NMR is priced at $8.73, while BTGO trades at $4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas BTGO's P/E ratio is -12.35. In terms of profitability, NMR's ROE is +0.10%, compared to BTGO's ROE of -0.27%. Regarding short-term risk, NMR is less volatile compared to BTGO. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BTGO's competition here
NMR vs DEFT Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, DEFT has a market cap of 172.6M. Regarding current trading prices, NMR is priced at $8.73, while DEFT trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas DEFT's P/E ratio is 6.63. In terms of profitability, NMR's ROE is +0.10%, compared to DEFT's ROE of +0.41%. Regarding short-term risk, NMR is less volatile compared to DEFT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check DEFT's competition here
NMR vs WHG Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, WHG has a market cap of 166.1M. Regarding current trading prices, NMR is priced at $8.73, while WHG trades at $17.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas WHG's P/E ratio is 21.10. In terms of profitability, NMR's ROE is +0.10%, compared to WHG's ROE of +0.06%. Regarding short-term risk, NMR is less volatile compared to WHG. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check WHG's competition here
NMR vs SWIN Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SWIN has a market cap of 160.9M. Regarding current trading prices, NMR is priced at $8.73, while SWIN trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SWIN's P/E ratio is -6.19. In terms of profitability, NMR's ROE is +0.10%, compared to SWIN's ROE of -0.03%. Regarding short-term risk, NMR is less volatile compared to SWIN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SWIN's competition here
NMR vs AXG Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, AXG has a market cap of 150.5M. Regarding current trading prices, NMR is priced at $8.73, while AXG trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas AXG's P/E ratio is -16.48. In terms of profitability, NMR's ROE is +0.10%, compared to AXG's ROE of -0.00%. Regarding short-term risk, NMR is less volatile compared to AXG. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check AXG's competition here
NMR vs SUIG Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SUIG has a market cap of 95.2M. Regarding current trading prices, NMR is priced at $8.73, while SUIG trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SUIG's P/E ratio is -0.16. In terms of profitability, NMR's ROE is +0.10%, compared to SUIG's ROE of -1.93%. Regarding short-term risk, NMR is less volatile compared to SUIG. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SUIG's competition here
NMR vs SRL Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SRL has a market cap of 93.3M. Regarding current trading prices, NMR is priced at $8.73, while SRL trades at $6.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SRL's P/E ratio is -43.79. In terms of profitability, NMR's ROE is +0.10%, compared to SRL's ROE of -0.01%. Regarding short-term risk, NMR is more volatile compared to SRL. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SRL's competition here
NMR vs TCJH Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, TCJH has a market cap of 89.6M. Regarding current trading prices, NMR is priced at $8.73, while TCJH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas TCJH's P/E ratio is -1.61. In terms of profitability, NMR's ROE is +0.10%, compared to TCJH's ROE of -0.55%. Regarding short-term risk, NMR is less volatile compared to TCJH. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TCJH's competition here
NMR vs SIEB Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, SIEB has a market cap of 75.3M. Regarding current trading prices, NMR is priced at $8.73, while SIEB trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas SIEB's P/E ratio is -13.14. In terms of profitability, NMR's ROE is +0.10%, compared to SIEB's ROE of -0.06%. Regarding short-term risk, NMR is more volatile compared to SIEB. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SIEB's competition here
NMR vs NAKA Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, NAKA has a market cap of 75.2M. Regarding current trading prices, NMR is priced at $8.73, while NAKA trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas NAKA's P/E ratio is -0.23. In terms of profitability, NMR's ROE is +0.10%, compared to NAKA's ROE of -0.85%. Regarding short-term risk, NMR is less volatile compared to NAKA. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check NAKA's competition here
NMR vs GRDI Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, GRDI has a market cap of 68.1M. Regarding current trading prices, NMR is priced at $8.73, while GRDI trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas GRDI's P/E ratio is 3.20. In terms of profitability, NMR's ROE is +0.10%, compared to GRDI's ROE of +0.25%. Regarding short-term risk, NMR is less volatile compared to GRDI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GRDI's competition here
NMR vs BTCS Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, BTCS has a market cap of 61.7M. Regarding current trading prices, NMR is priced at $8.73, while BTCS trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas BTCS's P/E ratio is -0.79. In terms of profitability, NMR's ROE is +0.10%, compared to BTCS's ROE of -0.73%. Regarding short-term risk, NMR is less volatile compared to BTCS. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BTCS's competition here
NMR vs DOMH Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, DOMH has a market cap of 52.3M. Regarding current trading prices, NMR is priced at $8.73, while DOMH trades at $3.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas DOMH's P/E ratio is -1.84. In terms of profitability, NMR's ROE is +0.10%, compared to DOMH's ROE of -0.47%. Regarding short-term risk, NMR is less volatile compared to DOMH. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check DOMH's competition here
NMR vs ADEX-WT Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, ADEX-WT has a market cap of 47.9M. Regarding current trading prices, NMR is priced at $8.73, while ADEX-WT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas ADEX-WT's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to ADEX-WT's ROE of +0.25%. Regarding short-term risk, NMR is less volatile compared to ADEX-WT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ADEX-WT's competition here
NMR vs PLUT Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, PLUT has a market cap of 47.4M. Regarding current trading prices, NMR is priced at $8.73, while PLUT trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas PLUT's P/E ratio is -8.83. In terms of profitability, NMR's ROE is +0.10%, compared to PLUT's ROE of -0.08%. Regarding short-term risk, NMR is less volatile compared to PLUT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PLUT's competition here
NMR vs HGBL Comparison June 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 25.5B. In comparison, HGBL has a market cap of 46.9M. Regarding current trading prices, NMR is priced at $8.73, while HGBL trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.77, whereas HGBL's P/E ratio is 13.50. In terms of profitability, NMR's ROE is +0.10%, compared to HGBL's ROE of +0.05%. Regarding short-term risk, NMR is less volatile compared to HGBL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HGBL's competition here